Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% ...

Researchers from the Belgian Federal Institute Sciensano, as part of the DARWIN project, have developed a proof-of-concept ...

An expert discusses the evolution of ROS1 testing in non-small cell lung cancer, highlighting the shift from FISH-based ...

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

Pharmaceutical scientists at the National University of Singapore (NUS) have developed a method that can measure the kinetic efficiency of an enzyme against more than 200,000 potential peptide ...

Every three seconds, one life is lost to sepsis, according to the Global Sepsis Alliance. It is a life-threatening, dysregulated immune response to infection and remains a leading cause of death ...

Researchers from the University of Birmingham's Bladder Cancer Research Center have used a new method to detect chemical ...

The global ovarian cancer diagnostics market is set to witness a growth rate of ~6% in the next 5 years. Rising incidence of ...

According to MarketsandMarkets™, The bacteriological testing market is valued at USD 25.83 billion in 2025. It is projected ...

The Federal Circuit recently reversed a $4.7M verdict in a patent lawsuit involving two patents concerning next-generation sequencing methods—U.S. Patent Nos. 10,017,810 and 10,450,597. Both patents ...

The researchers from the Belgian Federal Institute Sciensano, as part of the DARWIN project, have developed a groundbreaking proof-of-concept for ...

The global transcriptomics market size was US$ 6201.6 million in 2021. The global transcriptomics market size is forecast to reach US$ 11497.7 million by 2030, growing at a compound annual growth rate ...